Stefanie Corradini 🌟 (@stef_corradini) 's Twitter Profile
Stefanie Corradini 🌟

@stef_corradini

Radiation Oncologist @LMU_RadOnc | Dedicated to brachytherapy | SGRT | and MRgRT | views are my own

ID: 1215009659108646912

linkhttps://www.linkedin.com/in/stefanie-corradini-394161166/ calendar_today08-01-2020 20:37:42

716 Tweet

1,1K Followers

630 Following

Stefanie Corradini 🌟 (@stef_corradini) 's Twitter Profile Photo

Congratulations to the only Radiation Oncologist with his own hashtag #whereispeterhoskin on being awarded the Marie Curie Award at #WCB24 👏🏻👏🏻 #thisisbrachytherapy

Congratulations to the only Radiation Oncologist with his own hashtag #whereispeterhoskin on being awarded the Marie Curie Award at #WCB24 👏🏻👏🏻 

#thisisbrachytherapy
Stefanie Corradini 🌟 (@stef_corradini) 's Twitter Profile Photo

🍻🥨Oktoberfest Lectures LMU Radiation Oncology! 🎓 🗓️ 24. September at 9:30am 📍 @ St. Vinzenzhaus Munich Join us for a symposium on single-fraction Radiotherapy featuring a truly 🌟 stellar faculty! 👉🏻registration: lmy.de/riUHq

🍻🥨Oktoberfest Lectures <a href="/LMU_RadOnc/">LMU Radiation Oncology</a>! 🎓

🗓️ 24. September at 9:30am
📍 @ St. Vinzenzhaus Munich 

Join us for a symposium on single-fraction Radiotherapy featuring a truly 🌟 stellar faculty!

👉🏻registration: lmy.de/riUHq
Shankar Siva (@_shankarsiva) 's Twitter Profile Photo

🇩🇪🍺Michael Chuong opens the Oktoberfest Lectures! Congratulations to Stefanie Corradini 🌟 for organising a provocative topic - “one treatment, lasting impact” 👏🏽👏🏽👏🏽 #radonc #radiotherapy

🇩🇪🍺<a href="/MikeChuongMD/">Michael Chuong</a> opens the Oktoberfest Lectures! Congratulations to <a href="/stef_corradini/">Stefanie Corradini 🌟</a> for organising a provocative topic - “one treatment, lasting impact” 👏🏽👏🏽👏🏽 #radonc #radiotherapy
Shankar Siva (@_shankarsiva) 's Twitter Profile Photo

🍺🍻🇩🇪 Oktoberfest lectures #radonc - Thomas Zilli 🇨🇭and Joost Verhoeff 🇳🇱 speak about single fraction #radiotherapy. I learned that beer was brewed a long time ago! Oh - and that RADIOSURGERY is being tested in Ventricular arrhythmia 🫀and #prostatecancer.

🍺🍻🇩🇪 Oktoberfest lectures #radonc - <a href="/ZilliThomas/">Thomas Zilli</a> 🇨🇭and <a href="/joostverhoeff/">Joost Verhoeff</a> 🇳🇱 speak about single fraction #radiotherapy. I learned that beer was brewed a long time ago! Oh - and that RADIOSURGERY is being tested in Ventricular arrhythmia 🫀and #prostatecancer.
Stefanie Corradini 🌟 (@stef_corradini) 's Twitter Profile Photo

🤯 Fantastic insights at the #XChange Symposium! Clemens Cyran of LMUradiology delivered a compelling talk on the future of #AI in #Radiology, followed by Frederik Klauschen’s fascinating discussion on AI-guided #pathology. #XChange24

🤯 Fantastic insights at the #XChange Symposium! Clemens Cyran of <a href="/LMU_Radiology/">LMUradiology</a> delivered a compelling talk on the future of #AI in #Radiology, followed by Frederik Klauschen’s fascinating discussion on AI-guided #pathology.
#XChange24
Stefanie Corradini 🌟 (@stef_corradini) 's Twitter Profile Photo

🌟 we had the pleasure of hosting the #Xchange24 Meeting on #ArtificialIntelligence in Radiation Oncology LMU Radiation Oncology ! 🤩 A special thank you to our incredible faculty for their contributions, and a huge shoutout to Tanja Hirschfeld, who presented her stunning art!

npj Digital Medicine (@npjdigitalmed) 's Twitter Profile Photo

This pilot study LMU Radiation Oncology tested a privacy-friendly way to share/ analyze cancer patient data between hospitals in Germany and Italy using federated analysis. The results showed good treatment outcomes with high local control and low toxicity, while protecting patient privacy.

This pilot study <a href="/LMU_RadOnc/">LMU Radiation Oncology</a> tested a privacy-friendly way to share/ analyze cancer patient data between hospitals in Germany and Italy using federated analysis. The results showed good treatment outcomes with high local control and low toxicity, while protecting patient privacy.
Shankar Siva (@_shankarsiva) 's Twitter Profile Photo

🙂 DESTROY-2 trial 🇮🇹 🔥 A quick reminder to those who worry about side effects with single fraction SABR - only 1x Grade 3 adverse event after 227 courses of stereotactic body #radiotherapy. It can be done safely! #radonc

🙂 DESTROY-2 trial 🇮🇹 🔥 A quick reminder to those who worry about side effects with single fraction SABR - only 1x Grade 3 adverse event after 227 courses of stereotactic body  #radiotherapy. It can be done safely! #radonc
Stefanie Corradini 🌟 (@stef_corradini) 's Twitter Profile Photo

🌟 Wrapped up an incredible 2.5 days at the #MRLinac course of ESTRO in beautiful Rome! 🇮🇹 With over 70 participants from around the world 🌎 this edition was filled with learning, collaboration and discussions. We were also fortunate to visit the Gemelli #RadOnc Department

🌟 Wrapped up an incredible 2.5 days at the #MRLinac course of <a href="/ESTRO_RT/">ESTRO</a> in beautiful Rome! 🇮🇹 

With over 70 participants from around the world 🌎 this edition was filled with learning, collaboration and discussions. We were also fortunate to visit the Gemelli #RadOnc Department
Erika Hamilton, MD (@erikahamilton9) 's Twitter Profile Photo

Icro Meattini presents EUROPA - ET alone or XRT alone in women >70 in luminal early #bcsm XRT ☢️ affected QHS less than E At 24 mo f/u, efficacy no diff More AEs with ET Big 🙋‍♀️: 2 yrs f/u not enough in ER+, will there be later recurrences? SABCS #SABCS24

<a href="/Icro_Meattini/">Icro Meattini</a> presents EUROPA - ET alone or XRT alone in women &gt;70 in luminal early #bcsm 

XRT ☢️ affected QHS less than E 

At 24 mo f/u, efficacy no diff 

More AEs with ET

Big 🙋‍♀️: 2 yrs f/u not enough in ER+, will there be later recurrences? 

<a href="/SABCSSanAntonio/">SABCS</a> 
#SABCS24
Elisabetta Bonzano MD, PhD (@to_be_elizabeth) 's Twitter Profile Photo

📌Does Postmastectomy Radiotherapy in 'Intermediate-Risk' Breast Cancer Impact Overall Survival? 👉🏻10-Year Results of the BIG 2-04 MRC SUPREMO Randomized Trial: On Behalf of the SUPREMO Trial Investigators by Prof Ian Kunkler #SABCS24 #day3 OncoAlert #OncoAlertAF

📌Does Postmastectomy Radiotherapy in 'Intermediate-Risk' Breast Cancer Impact Overall Survival? 
👉🏻10-Year Results of the BIG 2-04 MRC SUPREMO Randomized Trial: On Behalf of the SUPREMO Trial Investigators by  Prof Ian Kunkler
#SABCS24 #day3 <a href="/OncoAlert/">OncoAlert</a> #OncoAlertAF
Yakup Ergün (@dr_yakupergun) 's Twitter Profile Photo

#SABCS24 & NEJM IMSEMA trial: Axillary Surgery in Breast Cancer Omitting surgical axillary staging in patients with clinically node-negative, T1 (90%) or T2 BC undergoing BCS was noninferior to sentinel-lymph-node biopsy in terms of 5-year iDFS. nejm.org/doi/full/10.10…

#SABCS24  &amp; <a href="/NEJM/">NEJM</a>
IMSEMA trial: Axillary Surgery in Breast Cancer 

Omitting surgical axillary staging in patients with clinically node-negative, T1 (90%) or T2  BC undergoing BCS was noninferior to sentinel-lymph-node biopsy in terms of 5-year iDFS.

nejm.org/doi/full/10.10…
Shankar Siva (@_shankarsiva) 's Twitter Profile Photo

Our little Oz 🦘🇦🇺experience of cardiac ablation for 💔ventricular arrhythmia. 50-day author link here; authors.elsevier.com/c/1kiIB5VtUyaE…. Pictures say a thousand words! Or in this case, re-wiring a few cardiac circuits 😀 Peter Mac Radiation Oncology #radonc

Our little Oz 🦘🇦🇺experience of cardiac ablation for 💔ventricular arrhythmia. 50-day author link here; authors.elsevier.com/c/1kiIB5VtUyaE…. Pictures say a thousand words! Or in this case, re-wiring a few cardiac circuits 😀 <a href="/PeterMacRadOnc/">Peter Mac Radiation Oncology</a> #radonc